CAR T Cells Targeting FLT3 on AML Confer Potent Anti-Leukemic Activity and Act Synergistically with the FLT3 Inhibitor Midostaurin

被引：0
|
作者：
Jetani, Hardikkumar
Garcia-Cadenas, Irene
Nerreter, Thomas
Rydzek, Julian
Thomas, Simone
Herr, Wolfgang
Sierra, Jordi
Bonig, Halvard
Einsele, Hermann
Hudecek, Michael
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1351
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [41] Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AML
    Yilmaz, Musa
    Kantarjian, Hagop
    Short, Nicholas J.
    Reville, Patrick
    Konopleva, Marina
    Kadia, Tapan
    DiNardo, Courtney
    Borthakur, Gautam
    Pemmaraju, Naveen
    Maiti, Abhishek
    Jabbour, Elias
    Jain, Nitin
    Issa, Ghayas
    Takahashi, Koichi
    Sasaki, Koji
    Ohanian, Maro
    Pierce, Sherry
    Tang, Guillin
    Loghavi, Sanam
    Patel, Keyur
    Wang, Sa A.
    Garcia-Manero, Guillermo
    Andreeff, Michael
    Ravandi, Farhad
    Daver, Naval
    BLOOD CANCER JOURNAL, 2022, 12 (05)
  • [42] Hypomethylating agent and venetoclax with FLT3 inhibitor “triplet” therapy in older/unfit patients with FLT3 mutated AML
    Musa Yilmaz
    Hagop Kantarjian
    Nicholas J. Short
    Patrick Reville
    Marina Konopleva
    Tapan Kadia
    Courtney DiNardo
    Gautam Borthakur
    Naveen Pemmaraju
    Abhishek Maiti
    Elias Jabbour
    Nitin Jain
    Ghayas Issa
    Koichi Takahashi
    Koji Sasaki
    Maro Ohanian
    Sherry Pierce
    Guillin Tang
    Sanam Loghavi
    Keyur Patel
    Sa A. Wang
    Guillermo Garcia-Manero
    Michael Andreeff
    Farhad Ravandi
    Naval Daver
    Blood Cancer Journal, 12
  • [43] Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells
    Choi, Soo Jeong
    Moon, Myoung Ju
    Lee, So Deok
    Choi, Sang-Un
    Han, Sun-Young
    Kim, Yong-Chul
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (06) : 2033 - 2037
  • [44] NMS-03592088, a novel, potent FLT3, KIT and CSF1R inhibitor with activity in FLT3 positive acute myeloid leukemia patients with prior FLT3 inhibitor experience
    Curti, Antonio
    Rambaldi, Alessandro
    Cattaneo, Chiara
    Cairoli, Roberto
    Della Porta, Matteo
    Chiusolo, Patrizia
    Lussana, Federico
    Ubezio, Marta
    Mancini, Valentina
    Cano, Isabel
    Besliu, Carmen
    Claussen, Christian Hove
    Gatto, Rosalinda
    Crivori, Patrizia
    Colajori, Elena
    Somaschini, Alessio
    Davite, Cristina
    Isacchi, Antonella
    Ardini, Elena
    Mahnke, Lisa
    Montesinos, Pau
    CANCER RESEARCH, 2023, 83 (08)
  • [45] Mutations in the kinase domain of FLT3 confer resistance to the FLT3 inhibitor and associate with poor outcomes following conventional chemotherapy
    Kwon, J.
    Koh, Y.
    Kim, J.
    Ahn, K.
    Lee, D.
    Yoon, S.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S539 - S539
  • [46] The FLT3 inhibitor PKC412 exerts differential cell cycle effects on leukemic cells depending on the presence of FLT3 mutations
    T Odgerel
    J Kikuchi
    T Wada
    R Shimizu
    K Futaki
    Y Kano
    Y Furukawa
    Oncogene, 2008, 27 : 3102 - 3110
  • [47] The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells
    E Chang
    S Ganguly
    T Rajkhowa
    C D Gocke
    M Levis
    H Konig
    Leukemia, 2016, 30 : 1025 - 1032
  • [48] TARGETING FLT3 FOR IMMUNOTHERAPY IN AML: BITE® VS CART
    Rohrbacher, L.
    Nixdorf, D.
    Stadler, H.
    Brauchle, B.
    Maerkl, F.
    Phillip, N.
    Haenel, G.
    Marcinek, A.
    Kazerani, M.
    Goldstein, R. L.
    von Bergwelt, M.
    Kobold, S.
    Buecklein, V.
    Arvedson, T.
    Subklewe, M.
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S61 - S61
  • [49] Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of Overcoming a Variety of FLT3 Mutations
    Wang, Zhijie
    Cai, Jiongheng
    Ren, Jiwei
    Chen, Yun
    Wu, Yingli
    Cheng, Jie
    Jia, Kun
    Huang, Fei
    Cheng, Zitian
    Sheng, Tiancheng
    Song, Shiyu
    Heng, Hao
    Zhu, Yifan
    Tang, Weifang
    Li, Hongmei
    Lu, Tao
    Chen, Yadong
    Lu, Shuai
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (19) : 14664 - 14701
  • [50] FLT3: Biology and Molecular Targeting to Improve Outcome in AML
    Small, Donald
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S2 - S2
12345